Measles virus, immune control, and persistence

FEMS Microbiology Reviews

Volumn 36, Issue 3, 2012, Pages 649-662

  Griffin, Diane E ^a   Lin, Wen Hsuan ^a   Pan, Chien Hsiung ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adaptive immunity; CD8 + T cells; Innate immunity; Rhesus macaques; Subacute sclerosing panencephalitis; Virus clearance

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; IMMUNOGLOBULIN; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; MYELOID DIFFERENTIATION FACTOR 88; NUCLEOCAPSID PROTEIN; RNA HELICASE; STAT1 PROTEIN; STAT2 PROTEIN; TUMOR NECROSIS FACTOR; VIRUS ENVELOPE PROTEIN; VIRUS HEMAGGLUTININ; VIRUS RNA;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; B LYMPHOCYTE; BIRTH RATE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME ACTIVATION; HOST; HUMAN; IMMUNE RESPONSE; INFECTION; INNATE IMMUNITY; INTERFERON PRODUCTION; LYMPHOID TISSUE; MEASLES; MEASLES VIRUS; NONHUMAN; PROTEIN DOMAIN; REVIEW; SPLEEN; VIRAL CLEARANCE; VIRUS ATTACHMENT; VIRUS ATTENUATION; VIRUS ENVELOPE; VIRUS LATENCY; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; EXANTHEMA; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE TOLERANCE; MEASLES; MEASLES VIRUS; RNA, VIRAL;

MACACA MULATTA; MEASLES VIRUS;

EID: 84859423387     PISSN: 01686445     EISSN: 15746976     Source Type: Journal    
DOI: 10.1111/j.1574-6976.2012.00330.x     Document Type: Review

References (189)

1. Albertyn C, van der Plas H, Hardie D, Candy S, Tomoka T, LeePan E & Heckmann J (2011) Silent casualties from the measles outbreak in South Africa. S Afr Med J 101: 313-317.
2. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S & Randall RE (2004) The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. P Natl Acad Sci USA 101: 17264-17269.
3. Andres O, Obojes K, Kim KS, ter Meulen V & Schneider-Schaulies J (2003) CD46- and CD150-independent endothelial cell infection with wild-type measles viruses. J Gen Virol 84: 1189-1197.
4. Anlar B, Soylemezoglu F, Aysun S, Kose G, Belen D & Yalaz K (2001) Tissue inflammatory response in subacute sclerosing panencephalitis (SSPE). J Child Neurol 16: 895-900.
5. Auwaerter PG, Rota PA, Elkins WR, Adams RJ, DeLozier T, Shi Y, Bellini WJ, Murphy BR & Griffin DE (1999) Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J Infect Dis 180: 950-958.
6. Baczko K, Liebert UG, Billeter M, Cattaneo R, Budka H & ter Meulen V (1986) Expression of defective measles virus genes in brain tissues of patients with subacute sclerosing panencephalitis. J Virol 59: 472-478.
7. Baczko K, Lampe J, Liebert UG, Brinckmann U, ter Meulen V, Pardowitz I, Bucka H, Cosby SL, Isserte S & Rima BK (1993) Clonal expansion of hypermutated measles virus in a SSPE brain. Virology 197: 188-195.
8. Barrett T (1999) Morbillivirus infections, with special emphasis on morbilliviruses of carnivores. Vet Microbiol 69: 3-13.
9. Bazarsky E, Wolfson M, Galron D, Granot Y, Argov S, Isakov N & Rager-Zisman B (1997) Persistent measles virus infection of murine neuroblastoma cells differentially affects the expression of PKC individual isoenzymes. Virus Genes 15: 227-234.
10. Beckford AP, Kaschula ROC & Stephen C (1985) Factors associated with fatal cases of measles: a retrospective autopsy study. S Afr Med J 68: 858-863.
11. Bellini WJ, Englund G, Rozenblatt S, Arnheiter H & Richardson CD (1985) Measles virus P gene codes for two proteins. J Virol 53: 908-919.
12. Bellini WJ, Rota JS, Lowe LE, Katz RS, Dyken PR, Zaki SR, Shieh WJ & Rota PA (2005) Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis 192: 1686-1693.
13. Bieback K, Lien E, Klagge IM, Avota E, Schneider-Schaulies J, Duprex WP, Wagner H, Kirschning CJ, ter Meulen V & Schneider-Schaulies S (2002) Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol 76: 8729-8736.
14. Brody JA, Detels R & Sever JL (1972) Measles-antibody titres in sibships of patients with subacute sclerosing panencephalitis and controls. Lancet 1: 177-178.
15. Burgoon MP, Keays KM, Owens GP, Ritchie AM, Rai PR, Cool CD & Gilden DH (2005) Laser-capture microdissection of plasma cells from subacute sclerosing panencephalitis brain reveals intrathecal disease-relevant antibodies. P Natl Acad Sci USA 102: 7245-7250.
16. Burnstein T, Jacobsen LB, Zeman W & Chen TT (1974) Persistent infection of BSC-1 cells by defective measles virus derived from subacute sclerosing panencephalitis. Infect Immun 10: 1378-1382.
17. Caignard G, Guerbois M, Labernardiere JL, Jacob Y, Jones LM, Wild F, Tangy F & Vidalain PO (2007) Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-alpha/beta signaling. Virology 368: 351-362.
18. Caignard G, Bourai M, Jacob Y, Tangy F & Vidalain PO (2009) Inhibition of IFN-alpha/beta signaling by two discrete peptides within measles virus V protein that specifically bind STAT1 and STAT2. Virology 383: 112-120.
19. Campbell H, Andrews N, Brown KE & Miller E (2007) Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol 36: 1334-1348.
20. Cathomen T, Mrkic B, Spehner D, Drillien R, Naef R, Pavlovic J, Aguzzi A, Billeter MA & Cattaneo R (1998) A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J 17: 3899-3908.
21. Cattaneo R & Rose JK (1993) Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J Virol 67: 1493-1502.
22. Cattaneo R, Schmid A, Rebmann G, Baczko K, ter Meulen V, Bellini WJ, Rozenblatt S & Billeter MA (1986) Accumulated measles virus mutations in a case of subacute sclerosing panencephalitis. Interrupted matrix protein reading frame and transcription alteration. Virology 154: 97-109.
23. Cattaneo R, Rebmann G, Schmid A, Baczko K, ter Meulen V & Billeter MA (1987) Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J 6: 681-688.
24. Cattaneo R, Schmid A, Billeter MA, Sheppard RD & Udem SA (1988a) Multiple viral mutations rather than host factors cause defective measles virus gene expression in a subacute sclerosing panencephalitis cell line. J Virol 62: 1388-1397.
25. Cattaneo R, Schmid A, Eschle D, Baczko K, ter Meulen V & Billeter MA (1988b) Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 55: 255-265.
26. Cattaneo R, Kaelin K, Baczko K & Billeter MA (1989a) Measles virus editing provides an additional cysteine-rich protein. Cell 56: 759-764.
27. Cattaneo R, Schmid A, Spielhofer P et al. (1989b) Mutated and hypermutated genes of persistent measles viruses which caused lethal human brain diseases. Virology 173: 415-425.
28. Centers for Disease Control (2009) Global Measles Mortality, 2000-2008. MMWR 58: 1321-1326.
29. Childs KS, Andrejeva J, Randall RE & Goodbourn S (2009) Mechanism of mda-5 Inhibition by paramyxovirus V proteins. J Virol 83: 1465-1473.
30. Colf LA, Juo ZS & Garcia KC (2007) Structure of the measles virus hemagglutinin. Nat Struct Mol Biol 14: 1227-1228.
31. Condack C, Grivel JC, Devaux P, Margolis L & Cattaneo R (2007) Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration. J Infect Dis 196: 541-549.
32. Dawson JR (1934) Cellular inclusions in cerebral lesions of epidemic encephalitis. Arch Neurol Psychiatry 31: 685-700.
33. de Swart RL, Ludlow M, de Witte L, Yanagi Y, van Amerongen G, McQuaid S, Yuksel S, Geijtenbeek TBH, Duprex WP & Osterhaus A (2007) Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog 3: 1771-1781.
34. de Vries RD, Yuksel S, Osterhaus AD & de Swart RL (2010) Specific CD8(+) T-lymphocytes control dissemination of measles virus. Eur J Immunol 40: 388-395.
35. Detels R, Brody JA, McNew J & Edgar AH (1973) Further epidemiological studies of subacute sclerosing panencephalitis. Lancet 2: 11-14.
36. Devaux P, Hudacek AW, Hodge G, Reyes-Del Valle J, McChesney MB & Cattaneo R (2011) A recombinant measles virus unable to antagonize STAT1 function cannot control inflammation and is attenuated in rhesus monkeys. J Virol 85: 348-356.
37. Dittmar S, Harms H, Runkler N, Maisner A, Kim KS & Schneider-Schaulies J (2008) Measles virus-induced block of transendothelial migration of T lymphocytes and infection-mediated virus spread across endothelial cell barriers. J Virol 82: 11273-11282.
38. Dorig RE, Marcil A, Chopra A & Richardson CD (1993) The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75: 295-305.
39. Dubois-Dalcq M, Coblentz JM & Pleet AB (1974) Subacute sclerosing panencephalitis: unusual nuclear inclusions and lengthy clinical course. Arch Neurol 31: 355-363.
40. Duhen T, Herschke F, Azocar O et al. (2010) Cellular receptors, differentiation and endocytosis requirements are key factors for type I IFN response by human epithelial, conventional and plasmacytoid dendritic infected cells by measles virus. Virus Res 152: 115-125.
41. Duprex WP, McQuaid S, Roscic-Mrkic B, Cattaneo R, McCallister C & Rima BK (2000) In vitro and in vivo infection of neural cells by a recombinant measles virus expressing enhanced green fluorescent protein. J Virol 74: 7972-7979.
42. Ehrengruber MU, Ehler E, Billeter M & Naim HY (2002) Measles virus spreads in rat hippocampal neurons by cell-to-cell contact and in a polarized fashion. J Virol 76: 5720-5728.
43. Embree JE, Datta P, Stackiw W, Sekla L, Braddick M, Kreiss JK, Pamba H, Wamola I, Ndinya-Achola JO & Law BJ (1992) Increased risk of early measles in infants of human immunodeficiency virus type 1-seropositive mothers. J Infect Dis 165: 262-267.
44. Enders JF, McCarthy K, Mitus A & Cheatham WJ (1959) Isolation of measles virus at autopsy in cases of giant cell pneumonia without rash. N Engl J Med 261: 875-881.
45. Endo A, Izumi H, Miyashita M, Taniguchi K, Okubo O & Harada K (2001) Current efficacy of postexposure prophylaxis against measles with immunoglobulin. J Pediatr 138: 926-928.
46. Erlenhofer C, Duprex WP, Rima BK, ter Meulen V & Schneider-Schaulies J (2002) Analysis of receptor (CD46, CD150) usage by measles virus. J Gen Virol 83: 1431-1436.
47. Esiri MM, Oppenheimer DR, Brownell B & Haire M (1982) Distribution of measles antigen and immunoglobulin containing cells in the CNS in subacute sclerosing panencephalitis (SSPE) and atypical measles encephalitis. J Neurol Sci 53: 29-43.
48. Esolen LM, Takahashi K, Johnson RT, Vaisberg A, Moench TR, Wesselingh SL & Griffin DE (1995) Brain endothelial cell infection in children with acute fatal measles. J Clin Invest 96: 2478-2481.
49. Fernandez-Munoz R & Celma ML (1992) Measles virus from a long-term persistently infected human T lymphoblastoid cell line, in contrast to the cytocidal parental virus, establishes an immediate persistence in the original cell line. J Gen Virol 73: 2195-2202.
50. Finke D, Brinckmann UG, ter Meulen V & Liebert UG (1995) Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J Virol 69: 5469-5474.
51. Fishman D, Wolfson M, Bazarski E, Segal S & Rager-Zisman B (1997) The effects of measles virus persistent infection on AP-1 transcription factor binding in neuroblastoma cells. FEBS Lett 410: 191-194.
52. Freeman JM, Magoffin RL, Lennette EH & Herndon RM (1967) Additional evidence of the relation between subacute inclusion-body encephalitis and measles virus. Lancet 2: 129-131.
53. Friedrichs WE, Reddy SV, Bruder JM, Cundy T, Cornish J, Singer FR & Roodman GD (2002) Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease. J Bone Miner Res 17: 145-151.
54. Fujinami RS & Oldstone MBA (1979) Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature 279: 529-530.
55. Furuse Y, Suzuki A & Oshitani H (2010) Origin of measles virus: divergence from rinderpest virus between the 11th and 12th centuries. Virol J 7: 52.
56. Garenne M (1994) Sex differences in measles mortality: a world review. Int J Epidemiol 23: 632-642.
57. Good RA & Zak SJ (1956) Disturbances in gammaglobulin synthesis as "experiments of nature". Pediatrics 18: 109-149.
58. Grais RF, Dubray C & Gerstl Seal (2007) Unacceptably high mortality related to measles epidemics in Niger, Nigeria, and Chad. PLoS Med 4: 0122-0129.
59. Griffin DE, Ward BJ, Jauregui E, Johnson RT & Vaisberg A (1990) Natural killer cell activity during measles. Clin Exp Immunol 81: 218-224.
60. Haase AT, Ventura P, Gibbs CJ Jr & Tourtellotte WW (1981) Measles virus nucleotide sequences: detection by hybridization in situ. Science 212: 672-675.
61. Haase AT, Stowring L, Ventura P, Burks J, Ebers G, Tourtellotte W & Warren K (1984) Detection by hybridization of viral infection of the human central nervous system. Ann N Y Acad Sci 436: 103-108.
62. Hall WW, Lamb RA & Choppin PW (1979) Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis. P Natl Acad Sci USA 76: 2047-2051.
63. Halsey NA, Modlin JF, Jabbour JT, Dubey L, Eddins DL & Ludwig DD (1980) Risk factors in subacute sclerosing panencephalitis: a case-control study. Am J Epidemiol 111: 415-424.
64. Hashiguchi T, Kajikawa M, Maita N, Takeda M, Kuroki K, Sasaki K, Kohda D, Yanagi Y & Maenaka K (2007) Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. P Natl Acad Sci USA 104: 19535-19540.
65. Hashiguchi T, Ose T, Kubota M, Maita N, Kamishikiryo J, Maenaka K & Yanagi Y (2011) Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM. Nat Struct Mol Biol 18: 135-141.
66. He B, Paterson RG, Stock N, Durbin JE, Durbin RK, Goodbourn S, Randall RE & Lamb RA (2002) Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-beta induction and interferon signaling. Virology 303: 15-32.
67. Helin E, Vainionpaa R, Hyypia T, Julkunen I & Matikainen S (2001) Measles virus activates NF-kappa B and STAT transcription factors and production of IFN-alpha/beta and IL-6 in the human lung epithelial cell line A549. Virology 290: 1-10.
68. Herndon RM & Rubinstein LJ (1968) Light and electron microscopy observations on the development of viral particles in the inclusions of Dawson's encephalitis (subacute sclerosing panencephalitis). Neurology 18: 8-20.
69. Horzinek MC (2011) Rinderpest: the second viral disease eradicated. Vet Microbiol 149: 295-297.
70. Indoh T, Yokota S, Okabayashi T, Yokosawa N & Fujii N (2007) Suppression of NF-kappaB and AP-1 activation in monocytic cells persistently infected with measles virus. Virology 361: 294-303.
71. Jabbour JT, Duenas DA, Sever JL, Krebs HM & Horta-Barbosa L (1972) Epidemiology of subacute sclerosing panencephalitis: a report of the SSPE registry. J Am Med Assoc 220: 959-962.
72. Jaye A, Magnusen AF, Sadiq AD, Corrrah T & Whittle HC (1998) Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children. J Clin Invest 102: 1969-1977.
73. Jin L, Beard S, Hunjan R, Brown DW & Miller E (2002) Characterization of measles virus strains causing SSPE: a study of 11 cases. J Neurovirol 8: 335-344.
74. Kaiserlian D & Dubois B (2001) Dendritic cells and viral immunity: friends or foes? Semin Immunol 13: 303-310.
75. Katayama Y, Hotta H, Nishimura A, Tatsuno Y & Homma M (1995) Detection of measles virus nucleoprotein mRNA in autopsied brain tissues. J Gen Virol 76: 3201-3204.
76. Katayama Y, Kohso K, Nishimura A, Tatsuno Y, Homma M & Hotta H (1998) Detection of measles virus mRNA from autopsied human tissues. J Clin Microbiol 36: 299-301.
77. Katayama Y, Hirano A & Wong TC (2000) Human receptor for measles virus (CD46) enhances nitric oxide production and restricts virus replication in mouse macrophages by modulating production of alpha/beta interferon. J Virol 74: 1252-1257.
78. Kawashima H, Miyajima T, Mori T, Yuan L, Ogihara M, Kinoue K, Takekuma K & Hoshika A (1996) A case of intractable epilepsy positive for the detection of measles virus genome in the cerebrospinal fluid and peripheral mononuclear cells using reverse transcriptase-polymerase chain reaction. Brain Dev 18: 220-223.
79. Kemper C, Chan AC, Green JM, Brett KA, Murphy KM & Atkinson JP (2003) Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421: 388-392.
80. Kirk JL, Zhou AL, McQuaid S, Cosby SL & Allen IV (1991) Cerebral endothelial cell infection by measles virus in subacute sclerosing panencephalitis: ultrastructural and in situ hybridization evidence. Neuropathol Appl Neurobiol 17: 289-297.
81. Koschel K, Brinckmann U & Hoyningen-Huene VK (1995) Measles virus antisense sequences specifically cure cells persistently infected with measles virus. Virology 207: 168-178.
82. Kouomou DW & Wild TF (2002) Adaptation of wild-type measles virus to tissue culture. J Virol 76: 1505-1509.
83. Kuhne M, Brown DW & Jin L (2006) Genetic variability of measles virus in acute and persistent infections. Infect Genet Evol 6: 269-276.
84. Lawrence DM, Patterson CE, Gales TL, D'Orazio JL, Vaughn MM & Rall GF (2000) Measles virus spread between neurons requires cell contact but not CD46 expression, syncytium formation, or extracellular virus production. J Virol 74: 1908-1918.
85. Lemon K, de Vries RD, Mesman AW et al. (2011) Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog 7: e1001263.
86. Leopardi R, Hyypia T & Vainionpaa R (1992) Effect of interferon-alpha on measles virus replication in human peripheral blood mononuclear cells. APMIS 100: 125-131.
87. Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE & Cummings DA (2009) Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis 9: 291-300.
88. Liebert UG, Baczko K, Budka H & ter Meulen V (1986) Restricted expression of measles virus proteins in brains from cases of subacute sclerosing panencephalitis. J Gen Virol 67: 2435-2444.
89. Liebert UG, Schneider-Schaulies S, Baczko K & ter Meulen V (1990) Antibody-induced restriction of viral gene expression in measles encephalitis in rats. J Virol 64: 706-713.
90. Liston P & Briedis DJ (1994) Measles virus V protein binds zinc. Virology 198: 399-404.
91. Ludlow M, Allen I & Schneider-Schaulies J (2009) Systemic spread of measles virus: overcoming the epithelial and endothelial barriers. Thromb Haemost 102: 1050-1056.
92. Makhortova NR, Askovich P, Patterson CE, Gechman LA, Gerard NP & Rall GF (2007) Neurokinin-1 enables measles virus trans-synaptic spread in neurons. Virology 362: 235-244.
93. Masse N, Ainouze M, Neel B, Wild TF, Buckland R & Langedijk JP (2004) Measles virus (MV) hemagglutinin: evidence that attachment sites for MV receptors SLAM and CD46 overlap on the globular head. J Virol 78: 9051-9063.
94. McQuaid S & Cosby SL (2002) An immunohistochemical study of the distribution of the measles virus receptors, CD46 and SLAM, in normal human tissues and subacute sclerosing panencephalitis. Lab Invest 82: 403-409.
95. McQuaid S, Cosby SL, Koffi K, Honde M, Kirk J & Lucas SB (1998) Distribution of measles virus in the central nervous system of HIV-seropositive children. Acta Neuropathol 96: 637-642.
96. Menna HH, Collins AR & Flanagan TD (1975) Characterization of an in vitro persistent-state measles virus infection: establishment and virological characterization of the BGM/MV cell line. Infect Immun 11: 152-158.
97. Miller CA & Carrigan DR (1982) Reversible repression and activation of measles virus infection in neuronal cells. P Natl Acad Sci USA 79: 1629-1633.
98. Miller C, Farrington CP & Harbert K (1992) The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989. Int J Epidemiol 21: 998-1006.
99. Modlin JF, Jabbour JT, Witte JJ & Halsey NA (1977) Epidemiologic studies of measles, measles vaccine, and subacute sclerosing encephalitis. Pediatrics 59: 505-512.
100. Moench TR, Griffin DE, Obriecht CR, Vaisberg AJ & Johnson RT (1988) Acute measles in patients with and without neurological involvement: distribution of measles virus antigen and RNA. J Infect Dis 158: 433-442.
101. Mongkolsapaya J, Jaye A, Callan MFC, Magnusen AF, McMichael AJ & Whittle HC (1999) Antigen-specific expansion of cytotoxic T lymphocytes in acute measles virus infection. J Virol 73: 67-71.
102. Moss WJ (2007) Measles still has a devastating impact in unvaccinated populations. PLoS Med 4: e24.
103. Moss WJ & Griffin DE (2006) Global measles elimination. Nat Rev Microbiol 4: 900-908.
104. Moss WJ, Monze M, Ryon JJ, Quinn TC, Griffin DE & Cutts F (2002a) Prospective study of measles in hospitalized, human immunodeficiency virus (HIV)-infected and HIV-uninfected children in Zambia. Clin Infect Dis 35: 189-196.
105. Moss WJ, Ryon JJ, Monze M & Griffin DE (2002b) Differential regulation of interleukin (IL)-4, IL-5, and IL-10 during measles in Zambian children. J Infect Dis 186: 879-887.
106. Moss WJ, Fisher C, Scott S, Monze M, Ryon JJ, Quinn TC, Griffin DE & Cutts FT (2008) HIV type 1 infection is a risk factor for mortality in hospitalized Zambian children with measles. Clin Infect Dis 46: 523-527.
107. Muhlebach MD, Mateo M, Sinn PL et al. (2011) Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 480: 530-533.
108. Muscat M, Bang H, Wohlfahrt J, Glismann S & Molbak K (2009) Measles in Europe: an epidemiological assessment. Lancet 373: 383-389.
109. Myou S, Fujimura M, Yasui M, Ueno T & Matsuda T (1993) Bronchoalveolar lavage cell analysis in measles viral pneumonia. Eur Respir J 6: 1437-1442.
110. Nandy R, Handzel T, Zaneidou M, Biey J, Coddy RZ, Perry R, Strebel P & Cairns L (2006) Case-fatality rate during a measles outbreak in eastern Niger in 2003. Clin Infect Dis 42: 322-328.
111. Naniche D, Varior-Krishnan G, Cervoni F, Wild F, Rossi B, Rabourdin-Combe C & Gerlier D (1993) Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67: 6025-6032.
112. Naniche D, Yeh A, Eto DS, Manchester M, Friedman R & Oldstone BA (2000) Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of alpha/beta interferon production. J Virol 74: 7478-7484.
113. Niedermeyer HP, Gantumur T, Neubert WJ & Arnold W (2007) Measles virus and otosclerosis. Adv Otorhinolaryngol 65: 86-92.
114. Noyce RS, Bondre DG, Lin L-T, Sisson G, Tsao MS, Richardson CD & Ha MN (2011) Tumor cell marker PVRL4 (Nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog 7: 1002240.
115. Obojes K, Andres O, Kim KS, Daubener W & Schneider-Schaulies J (2005) Indoleamine 2, 3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon. J Virol 79: 7768-7776.
116. Ohno S, Seki F, Ono N & Yanagi Y (2003) Histidine at position 61 and its adjacent amino acid residues are critical for the ability of SLAM (CD150) to act as a cellular receptor for measles virus. J Gen Virol 84: 2381-2388.
117. Oldstone MB, Homann D, Lewicki H & Stevenson D (2002) One, two, or three step: measles virus receptor dance. Virology 299: 162-163.
118. Oldstone MBA, Dales S, Tishon A, Lewicki H & Martin L (2005) A role for dual viral hits in causation of subacute sclerosing panencephalitis. J Exp Med 202: 1185-1190.
119. Ono N, Tatsuo H, Hidaka Y, Aoki T & Minagawa HY (2001) Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol 75: 4399-4401.
120. Palosaari H, Parisien JP, Rodriguez JJ, Ulane CM & Horvath CM (2003) STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J Virol 77: 7635-7644.
121. Pan CH, Valsamakis A, Colella T, Nair N, Adams RJ, Polack FP, Greer CE, Perri S, Polo JM & Griffin DE (2005) Inaugural Article: modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles. P Natl Acad Sci USA 102: 11581-11588.
122. Patterson JB, Cornu TI, Redwine J, Dales S, Lewicki HA, Holz A, Thomas D, Billeter M & Oldstone MBA (2001) Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease. Virology 291: 215-225.
123. Patterson CE, Lawrence DM, Echols LA & Rall GF (2002) Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J Virol 76: 4497-4506.
124. Permar SR, Moss WJ, Ryon JJ, Monze M, Cutts F, Quinn TC & Griffin DE (2001) Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction. J Infect Dis 183: 532-538.
125. Permar SR, Klumpp SA, Mansfield KG et al. (2003) Role of CD8(+) lymphocytes in control and clearance of measles virus infection of rhesus monkeys. J Virol 77: 4396-4400.
126. Permar SR, Klumpp SA, Mansfield KG et al. (2004) Limited contribution of humoral immunity to the clearance of measles viremia in rhesus monkeys. J Infect Dis 190: 998-1005.
127. Pfaller CK & Conzelmann KK (2008) Measles virus V protein is a decoy substrate for IkappaB kinase alpha and prevents Toll-like receptor 7/9-mediated interferon induction. J Virol 82: 12365-12373.
128. Plaza JA & Nuovo GJ (2005) Histologic and molecular correlates of fatal measles infection in children. Diagn Mol Pathol 14: 97-102.
129. Polack FP, Auwaerter PG, Lee S-H, Nousari HC, Valsamakis A, Leiferman KM, Diwan A, Adams RJ & Griffin DE (1999) Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. Nat Med 5: 629-634.
130. Pueschel K, Tietz A, Carsillo M, Steward M & Niewiesk S (2007) Measles virus-specific CD4 T-cell activity does not correlate with protection against lung infection or viral clearance. J Virol 81: 8571-8578.
131. Rager-Zisman B, Egan JE, Kress Y & Bloom BR (1984) Isolation of cold-sensitive mutants of measles virus from persistently infected murine neuroblastoma cells. J Virol 51: 845-855.
132. Ramachandran A & Horvath CM (2010) Dissociation of paramyxovirus interferon evasion activities: universal and virus-specific requirements for conserved V protein amino acids in MDA5 interference. J Virol 84: 11152-11163.
133. Ramachandran A, Parisien JP & Horvath CM (2008) STAT2 is a primary target for measles virus V protein-mediated alpha/beta interferon signaling inhibition. J Virol 82: 8330-8338.
134. Rammohan KW, McFarland HF & McFarlin DE (1981) Induction of subacute murine measles encephalitis by monoclonal antibody to virus haemagglutinin. Nature 290: 588-589.
135. Rammohan KW, McFarland HF & McFarlin DE (1982) Subacute sclerosing panencephalitis after passive immunization and natural measles infection: role of antibody in persistence of measles virus. Neurology 32: 390-394.
136. Richard JL & Masserey Spicher V (2009) Large measles epidemic in Switzerland from 2006 to 2009: consequences for the elimination of measles in Europe. Euro Surveill 14: 1-9.
137. Riddell MA, Moss WJ, Hauer D, Monze M & Griffin D (2007) Slow clearance of measles virus RNA after acute infection. J Clin Virol 39: 312-317.
138. Riley-Vargas RC, Gill DB, Kemper C, Liszewski MK & Atkinson JP (2004) CD46: expanding beyond complement regulation. Trends Immunol 25: 496-503.
139. Rima BK & Duprex WP (2005) Molecular mechanisms of measles virus persistence. Virus Res 111: 132-147.
140. Rima BK, Davidson WB & Martin SJ (1977) The role of defective interfering particles in persistent infection of Vero cells by measles virus. J Gen Virol 35: 89-97.
141. Rima BK, Earle JAP, Yeo RP, Herlihy L, Baczko K, ter Meulen V, Carabana J, Caballero M, Celma ML & Fernandez-Munoz R (1995) Temporal and geographical distribution of measles virus genotypes. J Gen Virol 76: 1173-1180.
142. Robinzon S, Dafa-Berger A, Dyer MD, Paeper B, Proll SC, Teal TH, Rom S, Fishman D, Rager-Zisman B & Katze MG (2009) Impaired cholesterol biosynthesis in a neuronal cell line persistently infected with measles virus. J Virol 83: 5495-5504.
143. Roos RP, Graves MC, Wollmann RL, Chilcote RR & Nixon J (1981) Immunologic and virologic studies of measles inclusion body encephalitis in an immunosuppressed host: the relationship to subacute sclerosing panencephalitis. Neurology 31: 1263-1270.
144. Rustigian R (1966) Persistent infection of cells in culture by measles virus. I. Development and characteristics of HeLa sublines persistently infected with complete virus. J Bacteriol 92: 1792-1804.
145. Saha V, John TJ, Mukundan P, Gnanamuthu C, Prabhakar S, Arjundas G, Sayeed ZA, Kumaresan G & Srinivas K (1990) High incidence of subacute sclerosing panencephalitis in south India. Epidemiol Infect 104: 151-156.
146. Santiago C, Bjorling E, Stehle T & Casasnovas JM (2002) Distinct kinetics for binding of the CD46 and SLAM receptors to overlapping sites in the measles virus hemagglutinin protein. J Biol Chem 277: 32294-32301.
147. Santiago C, Celma ML, Stehle T & Casasnovas JM (2010) Structure of the measles virus hemagglutinin bound to the CD46 receptor. Nat Struct Mol Biol 17: 124-129.
148. Sato H, Honma R, Yoneda M, Miura R, Tsukiyama-Kohara K, Ikeda F, Seki T, Watanabe S & Kai C (2008) Measles virus induces cell-type specific changes in gene expression. Virology 375: 321-330.
149. Sawaishi Y, Yano T, Wantanabe Y & Takada G (1999) Migratory basal ganglia lesions in subacute sclerosing panencephalitis (SSPE): clinical implications of axonal spread. J Neurol Sci 168: 137-140.
150. Schlender J, Hornung V, Finke S, Gunthner-Biller M, Marozin S, Brzozka K, Moghim S, Endres S, Hartmann G & Conzelmann KK (2005) Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J Virol 79: 5507-5515.
151. Schmid A, Spielhofer P, Cattaneo R, Baczko K, ter Meulen V & Billeter MA (1992) Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus. Virology 188: 910-915.
152. Schneider U, von Messling V, Devaux P & Cattaneo R (2002) Efficiency of measles virus entry and dissemination through different receptors. J Virol 76: 7460-7467.
153. Schneider-Schaulies S, Kreth HW, Hofmann G, Billeter M & ter Meulen V (1991) Expression of measles virus RNA in peripheral blood mononuclear cells of patients with measles, SSPE, and autoimmune diseases. Virology 182: 703-711.
154. Schneider-Schaulies S, Schneider-Schaulies J, Schuster A, Bayer M, Pavlovic J & ter Meulen V (1994) Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. J Virol 68: 6910-6917.
155. Schneider-Schaulies S, Bieback K, Avota E, Klagge I & ter Meulen V (2002) Regulation of gene expression in lymphocytes and antigen-presenting cells by measles virus: consequences for immunomodulation. J Mol Med 80: 73-85.
156. Schnorr J-J, Schneider-Schaulies S, Simon-Jodicke A, Pavlovic J, Horisberger MA & ter Meulen V (1993) MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J Virol 67: 4760-4768.
157. Schuhmann KM, Pfaller CK & Conzelmann KK (2011) The measles virus V protein binds to p65 (RelA) to suppress NF-kappaB activity. J Virol 85: 3162-3171.
158. Shanks GD, Lee S-H, Howard A & Brunden KR (2011) Extreme mortality after first introduction of measles virus to the Polynesian Island of Rotuma, 1911. Am J Epidemiol 173: 1211-1222.
159. Sheppard RD, Raine CS, Bornstein MB & Udem SA (1986) Rapid degradation restricts measles virus matrix protein expression in a subacute sclerosing panencephalitis cell line. P Natl Acad Sci USA 83: 7913-7917.
160. Shingai M, Ayata M, Ishida H, Matsunaga I, Katayama Y, Seya T, Tatsuo H, Yanagi Y & Ogura H (2003) Receptor use by vesicular stomatitis virus pseudotypes with glycoproteins of defective variants of measles virus isolated from brains of patients with subacute sclerosing panencephalitis. J Gen Virol 84: 2133-2143.
161. Shirogane Y, Takeda M, Tahara M, Ikegame S, Nakamura T & Yanagi Y (2010) Epithelial-mesenchymal transition abolishes the susceptibility of polarized epithelial cell lines to measles virus. J Biol Chem 285: 20882-20890.
162. Sidorenko SP & Clark EA (2003) The dual-function CD150 receptor subfamily: the viral attraction. Nat Immunol 4: 19-24.
163. Sinn PL, Williams G, Vongpunsawad S, Cattaneo R & McCray PB Jr (2002) Measles virus preferentially transduces the basolateral surface of well-differentiated human airway epithelia. J Virol 76: 2403-2409.
164. Stephenson JR, Siddell SG & ter Meulen V (1981) Persistent and lytic infections with SSPE virus: a comparison of the synthesis of virus-specific polypeptides. J Gen Virol 57: 191-197.
165. Stubblefield P Sr, Widness M, Levine AD & Patterson CE (2011) T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue. J Virol 85: 3664-3676.
166. Takahashi M, Watari E, Shinya E, Shimizu T & Takahashi H (2007) Suppression of virus replication via down-modulation of mitochondrial short chain enoyl-CoA hydratase in human glioblastoma cells. Antiviral Res 75: 152-158.
167. Takaki H, Watanabe Y, Shingai M, Oshiumi H, Matsumoto M & Seya T (2011) Strain-to-strain difference of V protein of measles virus affects MDA5-mediated IFN-beta-inducing potential. Mol Immunol 48: 497-504.
168. Takasu T, Mgone JM, Mgone CS et al. (2003) A continuing high incidence of subacute sclerosing panencephalitis (SSPE) in the Eastern Highlands of Papua New Guinea. Epidemiol Infect 131: 887-898.
169. Takeuchi K, Takeda M, Miyajima N, Kobune F, Tanabayashi K & Tashiro M (2002) Recombinant wild-type and Edmonston strain measles viruses bearing heterologous H proteins: role of H protein in cell fusion and host cell specificity. J Virol 76: 4891-4900.
170. Takeuchi K, Miyajima N, Nagata N, Takeda M & Tashiro M (2003) Wild-type measles virus induces large syncytium formation in primary human small airway epithelial cells by a SLAM(CD150)-independent mechanism. Virus Res 94: 11-16.
171. Tamashiro VG, Perez HH & Griffin DE (1987) Prospective study of the magnitude and duration of changes in tuberculin reactivity during complicated and uncomplicated measles. Pediatr Infect Dis J 6: 451-454.
172. Tanabe M, Kurita-Taniguchi M, Takeuchi K, Takeda M, Ayata M, Ogura H, Matsumoto M & Seya T (2003) Mechanism of up-regulation of human toll-like receptor 3 secondary to infection of measles virus-attenuated strains. Biochem Biophys Res Commun 311: 39-48.
173. Tatsuo H, Ono N, Tanaka K & Yanagi Y (2000) SLAM (CDw150) is a cellular receptor for measles virus. Nature 406: 893-898.
174. Tenoever BR, Servant MJ, Grandvaux N, Lin R & Hiscott J (2002) Recognition of the measles virus nucleocapsid as a mechanism of IRF-3 activation. J Virol 76: 3659-3669.
175. Tishon A, Lewicki H, Andaya A, McGavern D, Martin L & Oldstone MB (2006) CD4 T cell control primary measles virus infection of the CNS: regulation is dependent on combined activity with either CD8 T cells or with B cells: CD4, CD8 or B cells alone are ineffective. Virology 347: 234-245.
176. Van Binnendijk RS, van den HS, van den KH, Kohl RH, Woonink F, Berbers GA, Conyn-van Spaendonck MA & Kimman TG (2003) Evaluation of serological and virological tests in the diagnosis of clinical and subclinical measles virus infections during an outbreak of measles in The Netherlands. J Infect Dis 188: 898-903.
177. Vongpunsawad S, Oezgun N, Braun W & Cattaneo R (2004) Selectively receptor-blind measles viruses: identification of residues necessary for SLAM or CD46-induced fusion and their localization on a new hemagglutinin structural model. J Virol 78: 302-313.
178. Wakefield AJ, Pittilo RM, Sim R, Cosby SL, Stephenson JR, Dhillon AP & Pounder RE (1993) Evidence of persistent measles virus infection in Crohn's disease. J Med Virol 39: 345-353.
179. Ward BJ, Johnson RT, Vaisberg A, Jauregui E & Griffin DE (1991) Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection. Clin Immunol Immunopathol 61: 236-248.
180. Ward SV, George CX, Welch MJ, Liou LY, Hahm B, Lewicki H, de la Torre JC, Samuel CE & Oldstone MB (2011) RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis. P Natl Acad Sci USA 108: 331-336.
181. Wear DJ & Rapp F (1971) Latent measles virus infection of the hamster central nervous system. J Immunol 107: 1593-1598.
182. Wolfson LJ, Grais RF, Luquero FJ, Birmingham ME & Strebel PM (2009) Estimates of measles case fatality ratios: a comprehensive review of community-based studies. Int J Epidemiol 38: 192-205.
183. Wong TC, Ayata M, Ueda S & Hirano A (1991) Role of biased hypermutation in evolution of subacute sclerosing panencephalitis virus from progenitor acute measles virus. J Virol 65: 2191-2199.
184. Yanagi Y, Ono N, Tatsuo H, Hashimoto K & Minagawa H (2002) Measles virus receptor SLAM (CD150). Virology 299: 155-161.
185. Yanagi Y, Takeda M & Ohno S (2006) Measles virus: cellular receptors, tropism and pathogenesis. J Gen Virol 87: 2767-2779.
186. Young KK, Heineke BE & Wechsler SL (1985) M protein instability and lack of H protein processing associated with nonproductive persistent infection of HeLa cells by measles virus. Virology 143: 536-545.
187. Yount JS, Gitlin L, Moran TM & Lopez CB (2008) MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai Virus defective interfering particles. J Immunol 180: 4910-4918.
188. Yu XL, Cheng YM, Shi BS et al. (2008) Measles virus infection in adults induces production of IL-10 and is associated with increased CD4+ CD25+ regulatory T cells. J Immunol 181: 7356-7366.
189. Zilliox MJ, Moss WJ & Griffin DE (2007) Gene expression changes in peripheral blood mononuclear cells during measles virus infection. Clin Vaccine Immunol 14: 918-923.